Ballicules.com
Not available in the U.S.

Atosiban

TRACTOCILE

Atosiban ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Atosiban ballicule

What it isOxytocin and V1a antagonist; tocolysis in preterm labor.

Why this oneIt suppresses contractions with far fewer maternal cardiovascular effects than beta agonists.

What limits itIt delays delivery without clearly improving neonatal outcome. Not US-approved.

Atosiban molecular structure (skeletal formula)
Molecular structure: Atosiban

FDA-approved for

Off-label

NO BOXED WARNINGS

Principal riskIt delays delivery without clearly improving neonatal outcome

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Sedation liability0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Open Atosiban in the interactive console ↗